Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.38% |
| 2 | Consumer Discretionary | 1.03% |
| 3 | Financials | 0.75% |
| 4 | Healthcare | 0.67% |
| 5 | Communication Services | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11401
Biomerica
BMRA
$5.22M
| $44.7K | ﹤0.01% |
12,718
+4,537
| +55% | +$23.1K |
|
|
ITRM
11402
DELISTED
Iterum Therapeutics
ITRM
| $44.6K | ﹤0.01% |
+38,483
| New | +$55.7K |
|
|
AISP
11403
Airship AI Holdings
AISP
$73.4M
| $44.4K | ﹤0.01% |
12,354
-9,893
| -44% | -$58.1K |
|
11404
CALL
Cerence
CRNC
$363M
| $44.1K | ﹤0.01% |
15,600
-26,000
| -63% | -$185K |
|
|
BCLI
11405
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $43.9K | ﹤0.01% |
8,613
+7,760
| +910% | +$58.2K |
|
|
SUP
11406
PUT
DELISTED
Superior Industries International
SUP
| $43.9K | ﹤0.01% |
13,500
+3,200
| +31% | +$11.5K |
|
11407
CALL
IHS Holding
IHS
$2.83B
| $43.8K | ﹤0.01% |
13,700
-34,900
| -72% | -$121K |
|
11408
CALL
LivePerson
LPSN
$33.4M
| $43.6K | ﹤0.01% |
5,013
-6,060
| -55% | -$58.2K |
|
|
XXII
11409
CALL
22nd Century Group
XXII
$2.42M
| – | – |
0
| – | – |
|
|
UNIT
11410
Uniti Group
UNIT
$2.47B
| $43.4K | ﹤0.01% |
14,875
-99,217
| -87% | -$416K |
|
11411
PUT
ESS Tech
GWH
$14.8M
| $43.3K | ﹤0.01% |
3,520
-2,300
| -40% | -$25.9K |
|
11412
PUT
Stereotaxis
STXS
$145M
| $43.1K | ﹤0.01% |
23,700
-15,600
| -40% | -$35K |
|
|
CTV
11413
DELISTED
Innovid Corp.
CTV
| $42.9K | ﹤0.01% |
23,203
-870,743
| -97% | -$1.87M |
|
11414
Sono-Tek
SOTK
$79.5M
| $42.8K | ﹤0.01% |
11,064
-1,121
| -9% | -$5.02K |
|
11415
PUT
Fortress Biotech
FBIO
$93.7M
| $42.8K | ﹤0.01% |
25,000
+15,000
| +150% | +$27.2K |
|
|
GRTS
11416
PUT
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $42.7K | ﹤0.01% |
68,900
-295,300
| -81% | -$249K |
|
|
BIMI
11417
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
| $42.7K | ﹤0.01% |
+33,361
| New | +$43K |
|
11418
PUT
Telos
TLS
$332M
| $42.6K | ﹤0.01% |
10,600
-7,300
| -41% | -$27.7K |
|
11419
PUT
Baytex Energy
BTE
$3.27B
| $42.5K | ﹤0.01% |
12,200
-3,300
| -21% | -$11.8K |
|
11420
PUT
Citizens
CIA
$199M
| $42.4K | ﹤0.01% |
+15,600
| New | +$39.2K |
|
11421
PUT
American Battery Technology Co
ABAT
$355M
| $42.3K | ﹤0.01% |
33,800
-19,900
| -37% | -$27.5K |
|
11422
CALL
RAVE Restaurant Group
RAVE
$44.2M
| $42.2K | ﹤0.01% |
21,300
-22,200
| -51% | -$43.9K |
|
11423
Usio Inc
USIO
$82.9M
| $42K | ﹤0.01% |
27,436
+6,056
| +28% | +$9.34K |
|
|
ATHE
11424
Alterity Therapeutics
ATHE
$86.6M
| $42K | ﹤0.01% |
+23,311
| New | +$46.9K |
|
11425
CALL
CBAK Energy Technology Ltd
CBAT
$82.4M
| $41.2K | ﹤0.01% |
+30,100
| New | +$37.8K |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass withdrew a net $65.7B in Q2 2024, closing 1,726 positions and reducing 5,607 holdings. Its most notable exit was iShares MSCI USA Quality Factor ETF, an estimated $26.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in NextEra Energy 7.299% Corporate Units worth $127M.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.